What are the key considerations for managing patients with uncontrolled…
Asthma is a heterogeneous disease and its management is multifactorial; many patients often…
The GINA 2020 strategy recommends a stepwise approach to asthma management. As part of step 4, LAMA is an option for add-on therapy to medium-dose ICS-LABA and, at step 5, LAMA is an option as an add-on therapy to high-dose ICS-LABA combination.1
How is LAMA positioned in the GINA guidelines?
The GINA 2020 strategy recommends a stepwise approach to asthma management. As part of step 4, LAMA is an option for add-on therapy to medium-dose ICS-LABA…
Speakers
Dr Tom Corbridge/Dr Matt Hegewald
Asthma Forward is a registered trade mark of the GSK group of companies.
©2022 GSK group of companies. All rights reserved.
SE-GBL-FVU-WCNT-200061 | December 2022